NextGen Healthcare and Mirth Launch Enterprise Interoperability Platform

HORSHAM, Pa.--NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, and its sister company, Mirth, LLC, a global leader in health information technology, announced today the launch of NextGen® Share, a national Health Information Service Provider (HISP) enabling clients to connect with external providers using industry standards widely adopted by ONC 2014 Edition certified EHR products. NextGen Share equips providers with Direct Secure Messaging capabilities for efficient coordination of care and meeting Meaningful Use Stage 2 Transitions of Care objectives.

A nationwide network connecting clients and non-NextGen Healthcare providers to support secure clinical data exchange, NextGen Share is the first joint solution from NextGen Healthcare and Mirth since Quality Systems, Inc., acquired Mirth Corporation in September of last year. It combines key strengths of NextGen Healthcare and Mirth products to create an interoperability solution that facilitates easy data exchange among providers aimed to improve care coordination processes and meet meaningful use (MU) requirements. NextGen Share will facilitate safe, secure, accurate and quick exchange of clinical data and provider referrals without leaving the Electronic Health Record (EHR) system.

As a HISP, the solution provides secure connectivity between NextGen Healthcare and non-NextGen Healthcare providers, a searchable provider directory, and message translation between supported protocols. Leveraging NextGen Share, clinical care information, C-CDAs, and attachments including referral request letters, intake notes, and images such as a photo taken of the patient’s injury, can be transmitted between peers, practices and health systems locally and nationally across all technology platforms. Additionally, users can search to find connected providers and organizations, compose and exchange a referral with clinical documents, and count such transactions toward their MU stage 2 reporting. The structured clinical information exchanged through NextGen Share empowers healthcare organizations by providing actionable data which can be discretely imported into the patient’s record.

“Finding ways to breakdown walls to interoperability and data fluidity is the catalyst that moves healthcare forward. As a result, organizations require interoperability partners who understand the needs of health care systems, patients and clinicians alike,” said Michael Lovett, executive vice president and general manager for NextGen Healthcare. “Interoperability holds tremendous promise in the use of data derived from patient care and our goal is to fulfill the vision of using technology to provide the healthcare industry with an unprecedented level of data exchange. By combining a robust electronic health record solution with first-class interoperability tools, we have developed the necessary tool to enable clients to easily communicate and share important clinical information via a secure and integrated messaging service with any provider. With increased competition and care quality and reimbursement at stake, it is imperative that healthcare organizations make the right choices in supportive technology and with the launch of NextGen Share, we are pleased to be on the leading-edge of innovation.”

About Mirth

Mirth, LLC, a wholly owned subsidiary of Quality Systems, Inc., is a global leader in health information technology that helps clients achieve interoperability across silo-structured data systems. Mirth's solutions are used daily by thousands of health professionals and institutions worldwide to streamline care management processes and to securely exchange health information across enterprises, communities and broad geographies. For more information, visit www.mirth.com.

About NextGen Healthcare

NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, connectivity and financial solutions, including revenue cycle management services for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen, Facebook at http://www.facebook.com/NextGenHealthcare or LinkedIn at http://www.linkedin.com/company/nextgen-healthcare-information-systems.

Certain statements in this news release are forward-looking statements within the meaning of the federal securities laws, including but not limited to those statements made by Michael Lovett related to interoperability, the Company’s future products and offerings, and developments and trends in the healthcare industry. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company’s expectations and projections. Factors that could cause the anticipated results to differ from those described in the forward-looking statements include the possibility that the products of Cerner or the Company will not achieve or sustain market acceptance; the impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in our software; changing economic, political or regulatory influences in the healthcare industry; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; and general economic conditions. Additional risks and uncertainties are set forth in the Company’s public filings with the U.S. Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. The Company expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.

© 2014 Quality Systems, Inc., Irvine, CA 92612

® marks owned by Quality Systems, Inc.

All other non-QSI Marks are the property of their respective owners

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.